Kwang Dong Pharmaceutical Co., Ltd. (KRX: 009290)

Market Cap	232.87B
Revenue (ttm)	1.61T
Net Income (ttm)	33.89B
Shares Out	40.08M
EPS (ttm)	845.10
PE Ratio	6.87
Forward PE	n/a
Dividend	100.00 (1.73%)
Ex-Dividend Date	n/a

Volume	39,659
Open	5,790.00
Previous Close	5,760.00
Day's Range	5,730.00 - 5,800.00
52-Week Range	5,480.00 - 8,500.00
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1963
• Employees: 1,050
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 009290

Financial Performance

In 2023, Kwang Dong Pharmaceutical's revenue was 1.51 trillion, an increase of 5.79% compared to the previous year's 1.43 trillion. Earnings were 36.97 billion, an increase of 52.91%.